Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases

ALK and ROS1 Overexpression is Very Rare in Colorectal Adenocarcinoma

(2015) Michelle Houang et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency

(2014) Angela Chou et al.   HUMAN PATHOLOGY

Should the grading of colorectal adenocarcinoma include microsatellite instability status?

(2014) Christophe Rosty et al.   HUMAN PATHOLOGY

Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer

(2014) Christopher W. Toon et al.   PLoS One

BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome

(2013) Christopher W. Toon et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer

(2013) Christopher W Toon et al.   MODERN PATHOLOGY

Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma

(2012) M Bullock et al.   ENDOCRINE-RELATED CANCER

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

(2011) S. Ogino et al.   CLINICAL CANCER RESEARCH

Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer

(2011) Ola Marzouk et al.   Cancers

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma

(2010) Geoffrey Hall et al.   PATHOLOGY

Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation

(2008) Brody Winn et al.   HUMAN PATHOLOGY